12967_2018_1673_MOESM3_ESM.tif (18.98 MB)

MOESM3 of CD25 and TGF-Î˛ blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer

figure

posted on 2018-10-25, 05:00 authored by Ning Pu, Guochao Zhao, Hanlin Yin, Jian-ang Li, Abulimiti Nuerxiati, Dansong Wang, Xuefeng Xu, Tiantao Kuang, Dayong Jin, Wenhui Lou, Wenchuan Wu

Additional file 3: Figure S2. The PD-1/PD-L1 expression in tumor tissue after treatments with anti-CD25 and anti-TGF-Î˛.

Funding

China Scholarship Council

History

Usage metrics

Keywords

Pancreatic ductal adenocarcinoma Immunotherapy Integrated immune ratio Regulatory T cell Program death receptor-1

Licence

CC BY + CC0